Lee Financial’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-896
| Closed | -$176K | – | 516 |
|
|
2020
Q4 | $176K | Hold |
896
| – | – | 0.05% | 123 |
|
|
2020
Q3 | $159K | Hold |
896
| – | – | 0.04% | 128 |
|
|
2020
Q2 | $207K | Hold |
896
| – | – | 0.06% | 119 |
|
|
2020
Q1 | $104K | Hold |
896
| – | – | 0.03% | 133 |
|
|
2019
Q4 | $171K | Hold |
896
| – | – | 0.04% | 125 |
|
|
2019
Q3 | $172K | Hold |
896
| – | – | 0.04% | 121 |
|
|
2019
Q2 | $153K | Hold |
896
| – | – | 0.03% | 143 |
|
|
2019
Q1 | $180K | Hold |
896
| – | – | 0.04% | 132 |
|
|
2018
Q4 | $168K | Hold |
896
| – | – | 0.05% | 124 |
|
|
2018
Q3 | $214K | Hold |
896
| – | – | 0.05% | 124 |
|
|
2018
Q2 | $237K | Hold |
896
| – | – | 0.06% | 145 |
|
|
2018
Q1 | $222K | Hold |
896
| – | – | 0.06% | 149 |
|
|
2017
Q4 | $121K | Hold |
896
| – | – | 0.04% | 141 |
|
|
2017
Q3 | $110K | Hold |
896
| – | – | 0.04% | 139 |
|
|
2017
Q2 | $86K | Hold |
896
| – | – | 0.03% | 157 |
|
|
2017
Q1 | $167K | Hold |
896
| – | – | 0.07% | 113 |
|
|
2016
Q4 | $97K | Buy |
+896
| New | +$97K | 0.05% | 140 |
|